CONTENTS:
- Psychometric properties of the credibility/expectancy questionnaire in individuals with opioid use disorder. Sezer Katar K., Zengin Ispir G., Danisman M., p. 129-136.
- Direct-to-definitive urine and oral fluid test results for unscreened and rarely screened drugs in individuals applying for methadone treatment in 7 U.S. states. Lee-Easton M.J., Magura S., Abu-Obaid R., Reed P., Allgaier B., Fish E., et al., p. 137-148.
- Building capacity for injectable diacetylmorphine and hydromorphone for the treatment of opioid use disorder: Identifying typical doses. Magel T., Arreola L.A.G., Guh D., MacDonald S., Harrison S., Schechter M., et al., p. 149-162.
- A qualitative inquiry into the challenges in overcoming heroin addiction among Chinese individuals who experience voluntary rehabilitation. Liu L., Tang Z., Li X., Chui W.H., p. 163-170.
- Effects of ayahuasca on gratitude and relationships with nature: A prospective, naturalistic study. Aday J.S., Bloesch E.K., Davis A.K., Domoff S.E., Scherr K., Woolley J.D., et al., p. 171-180.
- Psychedelic microdosing among young adults from Southern California. Harlow A.F., Hendricks P.S., Leventhal A.M., Barrington-Trimis J.L., p. 181-192.
- What predicts beneficial outcomes in psychedelic use? A quantitative content analysis of psychedelic health outcomes. Acevedo E.C., Uhler S., White K.P., Al-Shawaf L., p. 193-202.
- Policy and practice changes associated with a tobacco-free initiative in residential substance use disorder treatment. Campbell B.K., Le T., McCuistian C., Bonniot C., Delucchi K., Guydish J., p. 203-212.
- Driving under the influence of alcohol, cannabis, and Delta-8 THC: Perceived likelihood, risk perceptions, and behaviors. LoParco C.R., Olsson S.E., Greene K.M., Berg C.J., Walters S.T., Zhou Z., et al., p. 213-222.
- Sweating for sobriety: Exploring the relationship between exercise engagement and substance use disorders. Gustafsson B.J., Puljevic C., Davies E.L., Barratt M.J., Ferris J., Winstock A., et al., p. 223-233.